Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2020-07-08 | 2020-09-01 | 119752 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2020-12-11 | 2021-03-15 | 130037 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2021-07-05 | 2021-07-26 | 141843 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2017-06-08 | 2017-11-20 | 12281 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2023-03-23 | 2023-05-06 | 187721 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2024-04-26 | 2024-09-20 | 226342 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2024-04-26 | 2024-10-04 | 226321 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2024-04-26 | 2024-09-20 | 226324 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2017-06-08 | 2017-10-12 | 12283 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2017-03-10 | 2017-04-07 | 113 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2022-07-11 | 2022-08-22 | 164367 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2018-05-15 | 2018-10-19 | 49487 |
| APO-CLARITHROMYCIN | 250MG | TABLET | Resolved | 2023-09-07 | 2023-09-15 | 203828 |
| APO-CLARITHROMYCIN | 500MG | TABLET | Resolved | 2025-02-06 | 2025-02-28 | 249760 |
| APO-CLARITHROMYCIN | 250MG | TABLET | Resolved | 2023-12-08 | 2023-12-15 | 212928 |
| APO-CLARITHROMYCIN | 250MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221720 |
| APO-CLARITHROMYCIN | 500MG | TABLET | Resolved | 2023-10-20 | 2023-12-15 | 207722 |
| APO-CLARITHROMYCIN | 500MG | TABLET | Resolved | 2017-05-10 | 2017-06-23 | 9925 |
| APO-CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-05-05 | 116 |
| APO-CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-10-02 | 2021-07-15 | 95266 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |